🇺🇸 FDA
Pipeline program

RBD3000 Placebo Injection is a clear, colorless sterile solution for subcutaneous injection, which is formulated by 25 mM phosphate buffer

RC02T001

Phase 2 small_molecule active

Quick answer

RBD3000 Placebo Injection is a clear, colorless sterile solution for subcutaneous injection, which is formulated by 25 mM phosphate buffer for Mixed Dyslipidemia is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Mixed Dyslipidemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials